Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The assay effectively identifies compounds that affect immune cell activation.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

CD133+ cells are crucial for hair growth.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Cells that move well may improve hair loss treatments by entering hair follicles.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Transplanted bone marrow cells actively move, form clusters, and grow after transplantation.

Most Recessive Dystrophic Epidermolysis Bullosa patients with a specific mutation likely have Sephardic ancestry from about 500 years ago.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Scientists created a cell model to study and find treatments for a skin disease called RDEB.

CD34 is crucial for skin tumor development in mice.

ABCG2 protein marks stem-like skin cells in human epidermis.

c-Kit is important for heart regeneration and cancer development.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Hhip-Cre effectively targets dermal papilla cells for gene manipulation in hair biology.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.